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Purpose: To evaluate the safety and efficiency of vertebral angioplasty and stenting (VAS) in symptomatic patients.
Material and Methods: 97 angioplasties in 91 pts (M:69) mean age 68,2 ± 6,8 years (22-84) left 55. All pts had multivascular diseases: carotid 
(CA):61, subclavian (SA): 24, coronary:62.... Atheromatous lesions: 95, inflammatory: 2. Mean lesion length: 9,6 +/- 2,8 mm. Mean % stenosis 83.1 
± 7.8, mean arterial diameter : 4,8 ± 0,6 mm (4-6). 89 lesions at VO segment (ostium), 6 at V1 and 2 at V2 segments.
Indications for angioplasty: dizziness (91), bilateral weakness (11), visual changes (11), diplopia (10), drop attacks (19), TIA (12), ataxia (5). 
A protection device (filter) used in 8 pts. 17 SA angioplasties performed at the same time of VAS, 7 CA. All angioplasties performed by femoral 
approach, 4 by brachial approaches after failure of femoral approach. (2 successes).
Results: Technical success 95/97 (98%). Defined. 6 lesions treated by angioplasty alone: 3 VO (first 3 pts. 2 V1, 1 V2 lesion). 1 pt (inflammatory 
disease) treated by cutting balloon alone. 84 lesions treated with stents (direct stenting: 69). Peripheral balloon expandable stents (n=19), self 
expandable stents (n=4 for 3 V1 and one V2 lesions). 65 coronary stents (11 DES). 1 pt developed a TIA during the procedure. No neurological 
complications at 30 days Clinical success 89/91 (98%)
Post-procedure arterial diameter: 4,55 ± 0,8 mm (4-6). Mean residual stenosis 2,2 ± 3,5 %.
In 8 pts treated with protection devices, visible debris removed in 6 (4 Filterwire, 2 Fibernet) with the same amount of debris as during Carotid 
Stenting) 6 pts (9%) developed symptomatic restenosis during the follow-up (mean: 32.2±28.8 months). 3 after PTA alone, 1 after PTA and stent (1 
occlusion treated medically, 5 stenoses successfully treated with PTA). No restenosis after DES implantation at 1 year.
Conclusion: VAS can be performed safely and effectively with a high technical success rate, a low complication rate, a low restenosis rate and 
a durable clinical success in patients with symptomatic VA stenosis. Stents seem to improve immediate and long-term Results:  The role of 
protection devices has to be discussed.
